Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Molecular Imaging and Biology|March 31, 2015
MicroPET Evaluation of a Hydroxamate-Based MMP Inhibitor, [(18)F]FB-ML5, in a Mouse Model of Cigarette Smoke-Induced Acute Airway InflammationNathalie Matusiak, Aren van Waarde, Dennie Rozeveld, et al.
European Journal of Medicinal Chemistry|November 26, 2018
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFRRiccardo Castelli, Nicole Bozza, Andrea Cavazzoni, et al.
European Journal of Medicinal Chemistry|July 18, 2024
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell lineLorenzo Guidetti, Riccardo Castelli, Alfonso Zappia, et al.
Biochemical Pharmacology|October 5, 2025
Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replicationAlfonso Zappia, Francesca Romana Ferrari, Carmine Giorgio, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2025
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinomaSara Taranto, Jessica Faletti, Mariangela Tamburello, et al.
Frontiers in Oncology|April 12, 2019
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell LinesClaudia Fumarola, Nicole Bozza, Riccardo Castelli, et al.
Biochemical Pharmacology|February 15, 2026
The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptorsAndrea Blesio, Carmine Giorgio, Francesca Romana Ferrari, et al.
Oncotarget|June 1, 2018
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in miceClaudio Festuccia, Giovanni Luca Gravina, Carmine Giorgio, et al.
European Journal of Medicinal Chemistry|September 14, 2015
Δ(5)-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin systemRiccardo Castelli, Massimiliano Tognolini, Federica Vacondio, et al.
Bioorganic & Medicinal Chemistry|December 3, 2014
A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imagingNathalie Matusiak, Riccardo Castelli, Adriaan W Tuin, et al.
Pageof 6